XML 21 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Cash flows from operating activities:          
Net (loss) income $ (50,128) $ 5,844 $ 51,788 $ 74,589  
Adjustments to reconcile net income to net cash provided by operating activities:          
Depreciation and amortization     35,946 25,836  
Bad debt allowance (recovery)     466 (541)  
Deferred income taxes     (17,788) 7,853  
Stock-based compensation expense     32,853 23,617  
Amortization and write-off of deferred debt issuance costs     4,160 430  
Change in fair value of derivative     (9,198) 3,365  
Change in fair value of contingent consideration     0 (1,340)  
Foreign currency remeasurement loss (gain)     103 (9,067)  
Loss from investment accounted for using the equity method, net of tax 664 581 2,939 1,447  
Changes in assets and liabilities, net of effect from acquisitions:          
Accounts receivable     26,305 46,661  
Prepaid and other assets     11,310 8,907  
Accounts payable, accruals, and other liabilities     31,766 31,486  
Deferred compensation plan liabilities     86,608 2,487  
Deferred revenues     (36,598) (35,134)  
Income taxes payable, net of prepaid income taxes     (13,243) (4,571)  
Net cash provided by operating activities     207,417 176,025  
Cash flows from investing activities:          
Purchases of property and equipment and investment in capitalized software     (11,152) (13,533)  
Acquisitions, net of cash acquired of $37,837 and $2,064, respectively     (1,033,695) (68,920)  
Other investing activities     (3,000) (6,355)  
Net cash used in investing activities     (1,047,847) (88,808)  
Cash flows from financing activities:          
Proceeds from credit facilities     682,083 432,375  
Payments of credit facilities     (860,228) (201,125)  
Proceeds from convertible senior notes, net of discounts and commissions     1,233,377 0  
Payments of debt issuance costs     (5,643) (432)  
Purchase of capped call options     (51,555) 0  
Proceeds from term loan     0 125,000  
Payments of financing leases     (147) (141)  
Payments of acquisition debt and other consideration     (741) (2,034)  
Payments of dividends     (25,076) (412,852)  
Payments for shares acquired including shares withheld for taxes     (111,306) (72,476)  
Proceeds from Common Stock Purchase Agreement     0 58,349  
Proceeds from stock purchases under employee stock purchase plan     3,846 0  
Proceeds from exercise of stock options     5,039 3,206  
Net cash provided by (used in) financing activities     869,649 (70,130)  
Effect of exchange rate changes on cash and cash equivalents     4,530 (590)  
Increase in cash and cash equivalents     33,749 16,497  
Cash and cash equivalents, beginning of year     122,006 121,101 $ 121,101
Cash and cash equivalents, end of period $ 155,755 $ 137,598 155,755 137,598 $ 122,006
Supplemental information:          
Cash paid for income taxes     32,359 17,338  
Income tax refunds     7,820 1,630  
Interest paid     3,281 4,658  
Non-cash investing and financing activities:          
Shares issued related to acquisition     182,390 0  
Contingent acquisition consideration     5,581 1,902  
Deferred, non-contingent consideration, net     10,081 (141)  
Convertible senior notes expenses included in Accounts payable     375 0  
Capped call options expenses included in Accounts payable     50 0  
Share-settled Executive Bonus Plan awards     16,015 0  
Deferred compensation plan elective participant deferrals     $ 2,020 $ 2,602